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Introduction {#sec005}
============

Globally, lip, oral cavity, and pharyngeal cancers have been estimated to be responsible for 529,500 incident cases and 292,300 deaths in 2012, accounting for about 3.8% of all cancer cases and 3.6% of cancer deaths. \[[@pone.0218833.ref001]\] OC is highly prevalent in Indian subcontinent with tobacco chewing and smoking, betel quid chewing, alcohol consumption and human papilloma virus (HPV) are considered to be the most common risk factors. \[[@pone.0218833.ref002]--[@pone.0218833.ref003]\] In India, OC is the third most common cancers with (7.2) with high mortality and morbidity rate. \[[@pone.0218833.ref004]\] As unnoticeable initially, OC usually is diagnosed at later stages carrying 5-year survival rate of only 40--50%. \[[@pone.0218833.ref005],[@pone.0218833.ref006]\] Along with manifestations including pain, burning sensation \[[@pone.0218833.ref007]\], toothache, tooth mobility \[[@pone.0218833.ref008]\], OC is strongly associated with social and psychological morbidity \[[@pone.0218833.ref009],[@pone.0218833.ref010]\] leading to poor quality of life (QoL). \[[@pone.0218833.ref010]--[@pone.0218833.ref013]\] Despite of several advantages, the available treatment options induces functional impairments such as disabled mastication, deglutition, phonetics and facial disfigurement, consequently again decreasing the post-treatment QoL of these patients.

In recent decades, health-related QoL (HRQoL) has gained an increased importance in clinical practice and research. The HRQoL can be assessed using patient reported outcome measures (PROMs). The PROMs not only reveals patients' perspectives but also helps to monitor treatment responses. This allows clinicians to elaborate a more exhaustive clinical control of patients and formulate a comprehensive treatment protocol as per individual patient's needs and expectations. \[[@pone.0218833.ref014]\] This concept of HRQoL assessment using PROMs is gradually replacing the traditional indicators of health outcomes. \[[@pone.0218833.ref015]\] Traditionally considered indicators were mainly based on the clinical features and the treatment responses and thus lack the patient's perspective.

Currently, numerous PROMs have been available in the literature for use in OC patients. \[[@pone.0218833.ref016]--[@pone.0218833.ref020]\] These include European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Head and Neck-specific module (EORTC QLQ-H&N35), the University of Washington Quality of Life (UWQOL), Functional Assessment of Cancer Therapy- Head and Neck module FACT-H&N (v 4.0), Speech Handicap Index (SHI), Swallowing Quality of Life Questionnaire (SWAL-QOL), Cancer needs questionnaire, short form, head and neck cancer-specific (CNQ-SF-hn) and Oral Cancer Quality-of-life Questionnaire (QOL-OC). However, as they vary significantly with respect to their development and validation, none has clearly been considered as gold standard. Selecting an adequate PROM is a pre-requisite in order to obtain an optimal informative HRQoL data. Since, no review have been conducted systematically to assess the psychometric properties of the validation studies on PROMs for OC patients till date, the present systematic review was designed with the objectives of (i) identifying PROMs used in validation studies involving OC patients and (ii) to determine their measurement properties.

Materials and methods {#sec006}
=====================

This review was performed according to (i) the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) \[[@pone.0218833.ref021]\] statement ([S1 Table](#pone.0218833.s001){ref-type="supplementary-material"}), (ii) COnsensus based Standards for the selection of health Measurement INstruments (COSMIN) guidance. \[[@pone.0218833.ref022]\]

Search strategy {#sec007}
---------------

A comprehensive search was performed on 10^th^ January 2019 on electronic databases: Medline through PubMed, Scopus, Web of Science and CINAHL. A search strategy ([S2](#pone.0218833.s002){ref-type="supplementary-material"} and [S3](#pone.0218833.s003){ref-type="supplementary-material"} Tables) was developed to identify relevant publications. In addition, we also searched the reference lists of all relevant review papers.

Selection criteria {#sec008}
------------------

All full text original research papers that assessed HRQoL of adult OC patients (≥ 18 years old) using PROM, if the paper was a validation study or determined one or more psychometric properties of a PROM were considered as eligible articles. No restriction was applied on sample size, gender of the participants, country of origin of the study, date and language of the publication. Non-validation studies were excluded. As per Terwee et al. \[[@pone.0218833.ref023]\] criteria, publications including editorials and case reports were excluded.

Study selection {#sec009}
---------------

The titles and abstracts of the relevant studies were screened by two reviewers (SG and AG) independently. Accordingly, full texts of all potentially eligible papers were retrieved and screened by the same reviewers (SG and AG) independently. Any disagreements were resolved by discussion with third reviewer (SS).

Data extraction {#sec010}
---------------

Full text articles were assessed by two reviewers (SG and AG) again independently and extracted the following predefined data from each article: PROM used, country and language, study population, number of patients, mode of administration, number of domains, scoring methods and recall periods used. Additionally, data required to complete the COSMIN checklist assessment were also extracted.

Measurement properties {#sec011}
----------------------

The methodological quality of the included studies was evaluated by the same two reviewers independently using the COSMIN checklist and any disagreements were resolved by discussion with the third reviewer (SS). The checklist covers nine measurement properties: internal consistency, reliability, measurement error, content validity, construct validity, criterion validity, hypothesis testing, structural validity and responsiveness. Each measurement property was scored as per the quality of reporting by the studies and rated as 'excellent', 'good', 'fair' or 'poor'. An overall score of each study is then determined by the 'worst score counts' method. The methodological quality of each study was rated by taking the lowest score (worst score counts method) per domain. For example, if any of the items of the domain reliability was scored 'poor', the overall score for regarding the methodological quality of reliability was rated as 'poor'.

For each PROM, the psychometric results was determined according to Terwee et al. \[[@pone.0218833.ref024]\] and ranked as '+' positive, '?' indeterminate or '-' negative.

Results {#sec012}
=======

Search results {#sec013}
--------------

[Fig 1](#pone.0218833.g001){ref-type="fig"} shows the PRISMA flow diagram of the literature search and results. We identified 174 papers from the initial search from different electronic databases (PubMed:18, Web of Science: 46, Scopus:97, CINAHL:13) and 45 remained after excluding duplicates. After screening titles and abstracts for relevance, 33 articles were removed. Full text articles of remaining 12 papers were assessed in depth by two reviewers (SG and AG) for their eligibility, amongst which, five articles were excluded because of non-validation study and review articles. Finally, we included seven papers \[[@pone.0218833.ref016]--[@pone.0218833.ref020], [@pone.0218833.ref025],[@pone.0218833.ref026]\] that met the inclusion criteria in the present systematic review. All the studies were based on the observations made on the self-administered questionnaire in oral cancer.

![PRISMA flow diagram showing flow of information.](pone.0218833.g001){#pone.0218833.g001}

Study characteristics {#sec014}
---------------------

All the seven studies were conducted on adult OC and oropharyngeal cancer (OPC) patients. In total, 769 patients (range n = 38--213) were recruited. The mean age of the participants was between 53.84 and 62.3 years and a higher proportion of males (55.26% to 93.7%) was reported in all studies, with exception of one study \[[@pone.0218833.ref016]\] which had higher female participants (61.8%). Total five studies performed the clinical staging, among which 3 studies \[[@pone.0218833.ref016],[@pone.0218833.ref017],[@pone.0218833.ref026]\] had higher proportion of stage IV disease (35.4% to 42%) and remaining 2 studies reported more number of patients with stage II \[[@pone.0218833.ref018]\] and stage I OC. \[[@pone.0218833.ref020]\]

PROMs {#sec015}
-----

[Table 1](#pone.0218833.t001){ref-type="table"} shows characteristics of all 6 included PROMs, which were developed/validated in OC and OPC patients between 2008 (SHI) and 2018 (QOL-OC). Among six, only one PROMs was disease-specific (QOL-OC) and remaining five were generic (SHI, SWAL-QOL, Chinese version CNQ-SF-hn, Chinese version SHI and FACT-H&N). The number of items included in these PROMs ranged from 29 (QOL-OC) to 44 (SWAL-QOL) and had 2 (SHI) to 10 (SWAL-QOL) HRQoL domains. The scoring methods used by all 6 PROMs contained total scores and subscale scores. The target population of all the PROMs were patients with OC and OPC specifically. An average completion time of three PROMs was reported from 5 minutes (Chinese version CNQ-SF-hn) to 10.4 minutes (QOL-OC). The PROMs included in this review were originally developed/validated in The Netherlands (SHI, SWAL-QOL) \[[@pone.0218833.ref020],[@pone.0218833.ref025],[@pone.0218833.ref026]\], China (Chinese version SHI, QOL-OC) \[[@pone.0218833.ref017],[@pone.0218833.ref018]\], Taiwan (Chinese version CNQ-SF-hn) \[[@pone.0218833.ref019]\] and Malaysia (FACT-H&N) \[[@pone.0218833.ref016]\].

10.1371/journal.pone.0218833.t001

###### Overview of the included studies.

![](pone.0218833.t001){#pone.0218833.t001g}

  Sr. no.   Author (Year)                                        Questionnaire                                                           Acronym                       Mode of administration   Country/ language        Purpose of the measurement                                  HRQoL domains                                   Year of development/validation   Target population       Number of items        Scoring method              Completion time
  --------- ---------------------------------------------------- ----------------------------------------------------------------------- ----------------------------- ------------------------ ------------------------ ----------------------------------------------------------- ----------------------------------------------- -------------------------------- ----------------------- ---------------------- --------------------------- -----------------
  1\.       Rinkel RN et al. (2008) \[[@pone.0218833.ref025]\]   Speech Handicap Index                                                   SHI                           Self-administered        The Netherlands/Dutch    Speech problems of OC, PC patients                          S, PSF                                          2008                             Patients with OC, PC    30                     Subscale and total scores   NR
  2\.       Rinkel RN et al. (2009) \[[@pone.0218833.ref026]\]   Swallowing Quality of Life Questionnaire                                SWAL-QOL                      Self-administered        The Netherlands/ Dutch   Swallowing outcomes of OC patients                          FS, ED, ED, F, B, MH, SF, C, SL, F              2009                             Patients with OC, OPC   44                     Subscale and total scores   NR
  3\.       Chen SC et al. (2011) \[[@pone.0218833.ref017]\]     Cancer needs questionnaire, short form, head and neck cancer-specific   CNQ-SF-hn (Chinese-version)   Self-administered        Taiwan/Chinese           Oral cancer patients' care needs                            PSN, HIN, PDLN,PCSN, ICN, HNDN                  2011                             Patients with OC        36                     Subscale and total scores   5--15 minutes
  4\.       Doss JG et al. (2011) \[[@pone.0218833.ref016]\]     Functional Assessment of Cancer Therapy scale 4 (v 4.0)                 FACT-H&N (v 4.0)              Self-administered        Malaysia/Malay           HRQoL of OC patients                                        PWB, SWB EWB, FWB, HN                           2011                             Patients with OC        43                     Subscale and total scores   NR
  5\.       Li T et al. (2016) \[[@pone.0218833.ref018]\]        Speech Handicap Index                                                   SHI (Chinese-version)         Self-administered        China/Chinese            Speech problems of OC patients                              S, PSF                                          2016                             Patients with OC, OPC   30                     Subscale and total scores   NR
  6\.       Rinkel RN et al. (2015) \[[@pone.0218833.ref020]\]   Speech Handicap Index and Swallowing Quality of Life Questionnaire      SHI AND SWAL-QOL              Self-administered        The Netherlands/ Dutch   Speech problems & Swallowing outcomes of OC, OPC patients   S, PSF AND FS, ED, ED, F, B, MH, SF, C, SL, F   2015                             Patients with OC, OPC   SHI- 30 SWAL-QOL- 44   Subscale and total scores   10 minutes
  7\.       Nie M et al. (2018) \[[@pone.0218833.ref019]\]       Oral Cancer Quality-of-life Questionnaire                               QOL-OC                        Self-administered        China/Chinese            Quality of Life of OC patients                              PD, ET, SA, SC, DT                              2018                             Patients with OC        29                     Subscale and total scores   10.4 minutes

**SHI-** S: Speech, PSF: Psychosocial functions

**SWAL-QOL-** FS: Food selection, EDu: eating duration, ED: eating desire, F: fear, B: burden, MH: mental health, SF: social functioning, C: communication, SL: sleep, F: fatigue

**CNQ-SF-hn-** PSN: Psychological needs, HIN: health information needs, PDLN: physical and daily living needs, PCSN: patient care and support needs, ICN: patient care and support needs, HNDN: head and neck disease needs

**FACT-H&N (v 4.0)-** PWB: Physical well-being, SWB: social well-being, EWB: emotional well-being, FWB: functional well-being, HNSC: head & neck

**QOL-OC-** PD: Pain & discomfort, ET: eating, SA: saliva, SC: social contact, DT: diet

OC: Oral cancer, PC: Pharyngeal cancer, OPC: Oro-pharyngeal cancer, HRQoL: Health-related quality of life, NR: Not reported

Measurement properties {#sec016}
----------------------

An overview of the measurement properties of all the PROMs is presented in [Table 2](#pone.0218833.t002){ref-type="table"}.

10.1371/journal.pone.0218833.t002

###### Rating of measurement properties of the instruments.

![](pone.0218833.t002){#pone.0218833.t002g}

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Sr. no.   Author (Year)                                        Measurement instrument   Population              Sample size   Content validity   Construct validity   Internal consistency   Reliability   Absolute measurement error   Responsiveness   Interpretability
  --------- ---------------------------------------------------- ------------------------ ----------------------- ------------- ------------------ -------------------- ---------------------- ------------- ---------------------------- ---------------- ------------------
  1\.       Rinkel RN et al. (2008) \[[@pone.0218833.ref025]\]   SHI                      Patients with OC        92            ?                  \+                   ?                      ?             NR                           NR               NR

  2\.       Rinkel RN et al. (2009) \[[@pone.0218833.ref026]\]   SWAL-QOL                 Patients with OC        102           ?                  \+                   \+                     ?             NR                           NR               NR

  3\.       Chen SC et al. (2011) \[[@pone.0218833.ref017]\]     CNQ-SF-hn                Patients with OC        206           \+                 \+                   \+                     \+            NR                           NR               NR

  4\.       Doss JG et al. (2011) \[[@pone.0218833.ref016]\]     FACT-H&N\                Patients with OC, OPC   76            \+                 \+                   \+                     ?             NR                           NR               NR
                                                                 (v 4.0)                                                                                                                                                                                   

  5\.       Li T et al. (2016) \[[@pone.0218833.ref018]\]        SHI\                     Patients with OC, OPC   42            ?                  \+                   ?                      ?             NR                           NR               NR
                                                                 (Chinese-version)                                                                                                                                                                         

  6\.       Rinkel RN et al. (2015) \[[@pone.0218833.ref020]\]   SHI and SWAL-QOL         Patients with OC, PC    38            ?                  \+                   ?                      ?             NR                           NR               NR

  7\.       Nie M et al. (2018) \[[@pone.0218833.ref019]\]       QOL-OC                   Patients with OC, OPC   213           \+                 \+                   \+                     \+            NR                           NR               NR
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

OC: Oral cancer, PC: Pharyngeal cancer, OPC: Oro-pharyngeal cancer, +: Positive rating, ?: Indeterminate rating, NR: Not reported

### SHI {#sec017}

The SHI was developed by translating voice handicap index (VHI) into Dutch language. There was no information if the patients were involved in the initial development process. Moreover, it is not clear whether subject experts in the field were involved during this process. Two studies evaluated measurement properties of the SHI. In one study, the SHI was translated into Chinese language and assessed the cross-cultural validity along with other properties. \[[@pone.0218833.ref018]\] However, other study determined only the construct validity of the SHI. \[[@pone.0218833.ref020]\]

As it was unclear whether patients and experts were involved in the development process, content validity of the SHI was rated indeterminate. Evidence for excellent construct and structural validity was found. Good cross-cultural validity was reported for Chinese version. Internal consistency and reliability was rated indeterminate for both Dutch and Chinese version due to inadequate sample size.

### SWAL-QOL {#sec018}

SWAL-QOL was developed by back-translation method into Dutch language. There was no clear information whether patients and experts in the field were involved in development process. Thus, content validity was rated indeterminate. Good evidence was reported construct validity. Internal consistency and reliability was rated indeterminate. One study judged only the construct validity of the SWAL-QOL. \[[@pone.0218833.ref020]\]

### CNQ-SF-hn {#sec019}

CNQ-SF-hn was developed by adding few items to previously described CNQ-SF. These newly added items actually reflect unique care needs of head & neck (H&N) cancer patients. The content validity was rated positive because of extensive development process which had involved patients and experts in the field. Factor analysis for structural validity and further internal consistency analysis provided strong evidence for a six-factor structure and thus rated positive. The construct validity was determined by correlating the subscale and total scores of CNQ-SF-hn with other instruments (anxiety, depression, physical performance and QoL). Good evidence was reported for all the domains except for correlation between performance status and interpersonal/communication needs and between QoL and health information needs. Reliability was rated positive.

### FACT-H&N {#sec020}

FACT-H&N was translated into Malay language for use in Malaysian OC patients. The Malay-translated version was pretested for face and content validity. The FACT-H&N summary scale and subscale showed acceptable construct validity and internal consistency, thus rated positive. No information was provided regarding test-retest reliability and rated indeterminate.

### QOL-OC {#sec021}

QOL-OC is the only disease-specific PROM developed in China to assess QoL in OC patients. Content validity was rated positive as extensive process involved (included patients, experts in the field and referred previous questionnaires) in the development process. Factor analysis and subsequent internal consistency analysis supported strong evidence for a seven-factor structure. Good evidence was reported for test-retest reliability for summary scales and subscales except for shoulder and neck function scale which showed limited evidence. A moderate to significant correlation was noted between subscale and summary scales of QOL-OC and EORTC QLC-C30. None of the included studies reported information about the measurement properties measurement error responsiveness and interpretability.

Looking at the results of the present review, QOL-OC showed good content and construct validity and the instrument is reliable. The CNQ-SF-hn also demonstrated adequate psychometric properties because of its good internal consistency and reliability. Other instruments had reasonable measurement properties.

Discussion {#sec022}
==========

As per our first objective, we identified five generic and one disease-specific self-administered PROMs to assess HRQoL in OC patients. Our second objective was to determine the measurement properties of the PROMs. The information obtained from the studies included in the present review revealed that none of the studies reported complete assessment of all the measurement properties of the PROMs studied as per the COSMIN criteria. It is important to note that the quality of majority of the studies was recorded to be fair to poor quality. Moreover, none of the studies have determined measurement error and responsiveness. Surprisingly, one study has evaluated only construct validity of the studied PROMs. Despite the incomplete information in the identified studies, results of this review support disease-specific QOL-OC as a comprehensive PROM to measure HRQoL in OC patients. The CNQ-SF-hn also appeared to be quite suitable for use in OC patients. However, as it was developed/validated by considering H&N cancers, this generic PROM is bit extensive than QOL-OC.

The QOL-OC and CNQ-SF-hn were developed by involving patients and experts in the concerned field. Additionally, these PROMs were pilot tested for the comprehensiveness and intelligibility in patients' native language, assuring completeness and inclusion of relevant items for OC patients, particularly in QOL-OC. As the PROM was intended for use in H&N cancer patients, CNQ-SF-hn contained additional items, which might not deemed necessary for OC patients. Steinmann et al suggested that lesser length of PROM can be helpful to reduce the time of administration and thus, enhances patients' compliance. \[[@pone.0218833.ref027]\] Strong evidence was rated for internal consistency for both these studies as they have performed factor analysis with adequate sample size and provided subscale structures with outcomes per subscale. They have also correlated subscales and summary scales of these PROMs with other used relevant PROMs for OC. These finding of the present review indicates good evidence for content and construct validity of QOL-OC and moderate for CNQ-SF-hn.

Since accurate and reproducible measurements are pre-requisites for an adequate instrument, an acceptable reliability is essential. It was noticed that reliability was studied for QOL-OC and CNQ-SF-hn and demonstrated good evidence. Despite of moderate to good evidence for other PROMs used in OC patients, the evidence for measurement property reliability and measurement error were meager. The inadequate sample size used by the studies resulted in poor quality on reliability. We believe that this striking finding of this review indicates a clear need of re-evaluation of this particular property in future research.

Furthermore, all the studies presented herein intended to quantify the disease burden and its impact using constructs such asHRQoL and severity of symptoms. But, none of the PROMs has determined responsiveness, which can detect changes over time properly. This is an alarming finding of the present review as PROMs are popularly used nowadays as an indicator of quality of care in clinical practice and researches. Although interpretability is not a measurement property but is a meaningful requisite for the applicability of PROMs in research. Since, no study evaluated this, the evidence for interpretability is unknown. However, this does not mean that the PROMs presented herein have poor measurement properties and thus are of poor quality. Other medical fields also showed lack of adequate assessment of all measurement properties in good methodological studies. \[[@pone.0218833.ref028]--[@pone.0218833.ref030]\] Therefore there is an urgent need of further high quality methodological studies to properly assess and strengthen their measurement properties.

Even though clinicians and researchers can opt for any of the available PROMs as per their choice, the objective and psychometric properties of the PROMs should be taken into consideration while selection. \[[@pone.0218833.ref031]\] Our review results suggest that generic instruments such SHI, SWAL-QOL, CNQ-SF-hn and FACT-H&N have been used in OC patients. All these PROMs have been widely accepted in the scientific community as being valid, reliable and applicable to a variety of health disparities in H&N cancer patients. Despite the fact that these PROMs may measure burden of OC, they may lack sensitivity in identifying OC-specific problems and can provide misleading outcomes. In addition, SHI and SWAL-QOL are intended to measure speech and swallowing problems of OC patients mainly and limited in other HRQoL domains. Being OC-specific, QOL-OC may be more effective and identify OC-related symptoms and problems such as pain & discomfort, eating problems, oral dryness, diet changes etc. and their impacts on QoL. Since QOL-OC has been developed very recently, it has not been widely investigated. As it has scored more favorably using COSMIN review, we believe that QOL-OC needs to be perceived by the scientific community in the future research to further evaluate its measurement properties in different cultural and language contexts.

Strengths and limitations {#sec023}
-------------------------

This review is the first attempt to evaluate the methodological quality of the validation studies of PROMs used in OC patients by using PRISMA and COSMIN guidelines. The quality of the included studies was evaluated by two reviewers independently with the help of third reviewer in cases of disagreement. In addition, only those studies were selected in which target population were OC patients. We have searched extensively for papers in different electronic databases without any time and language restrictions to minimize chances of missing relevant publications. Even with the broad search strategy used, we could find only seven validation studies; demonstrating lack of literature in this area. The possibility of the publication bias cannot be ruled out. It could be possible that validation studies with negative results may have never been published. There could be chances that studies have been performed properly but not explained well enough as per COSMIN criteria, thus affecting their quality ratings.

Conclusion {#sec024}
==========

We identified five generic and one disease-specific PROM used in OC patients. Based on the results of the present review, we agree that QOL-OC may perform better than other available PROMs. As there is decreased QoL in OC patients from diagnosis (threat of cancer development) and even after treatment (uncertainty of successful outcomes), selecting an adequate PROM is a pre-requisite for clinicians. Therefore, we recommend implementation of this PROM in future research for detailed evaluation of patients' experiences and expectations of OC patients. We also recommend higher quality methodological studies for proper evaluation of measurement properties of other PROMs.
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